comparemela.com

Latest Breaking News On - Guillermo garcia manero - Page 1 : comparemela.com

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

United statesSouth koreaPushkar muthaMariat bourlonTycel jovelle phillipsTony mokLin wangPeter robert galleCharlene mantiaMarc hoffmannEric christensonSuzanne trudelManali kirtikumar kamdarGuillermo garcia maneroMartin reckTina cascone

Giants of Cancer Care® Announces the 12th Annual Class of Inductees

The 15 inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.

United statesUniversity of chicagoAdler planetariumRafael fonsecaCarola aghajanianFabrice andrMike hennessy jrGuillermo garcia maneroSolangeg petersRalphr weichselbaumEdwards kimMichaelj hennessyEthanm baschLynnm schuchterJosepha sparanoJulia paradizova

MD Anderson Research Highlights for February 7, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.

United statesCara haymakerEdwin roger parraGuillermo garcia maneroPawel mazurVivian crowderJeffrey myersJason huseJianjun zhangAbdelrahman yousefAlex batallerMeagan whisenantDan zhaoClinical cancer researchNature communicationsCancer center

MD Anderson Research Highlights for February 7, 2024

MD Anderson Research Highlights for February 7, 2024
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

United statesGuillermo garcia maneroPawel mazurCara haymakerAlex batallerJeffrey myersVivian crowderEdwin roger parraJason huseJianjun zhangAbdelrahman yousefMeagan whisenantDan zhaoNature communicationsClinical cancer researchCancer center

All-Oral Therapy Promising in Higher-Risk MDS, CMML

In small trial, overall response rate was 95%

United statesMike bassettSarit assoulineGuillermo garcia maneroAssoulines decitabineHospital at mcgill universityInternational working groupUniversity of texas md anderson cancer centerInternational prognostic scoring systemCancer centerJewish general hospitalMcgill university

vimarsana © 2020. All Rights Reserved.